Demars Financial Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
4,939
+1,212
+33% +$335K 0.3% 45
2026
Q1
$1.1M Buy
3,727
+627
+20% +$186K 0.36% 34
2025
Q4
$847K Buy
3,100
+64
+2% +$17.4K 0.28% 38
2025
Q3
$820K Buy
3,036
+451
+17% +$123K 0.28% 38
2025
Q2
$713K Buy
2,585
+283
+12% +$77K 0.27% 38
2025
Q1
$611K Buy
2,302
+32
+1% +$7.89K 0.26% 40
2024
Q4
$527K Buy
2,270
+134
+6% +$30.8K 0.23% 49
2024
Q3
$471K Buy
2,136
+79
+4% +$16.3K 0.22% 48
2024
Q2
$404K Buy
2,057
+87
+4% +$18K 0.19% 50
2024
Q1
$424K Sell
1,970
-382
-16% -$80.2K 0.21% 50
2023
Q4
$495K Buy
2,352
+124
+6% +$26.5K 0.26% 40
2023
Q3
$446K Buy
+2,228
New +$443K 0.26% 52
2020
Q2
Sell
-14,716
Closed -$2.54M 64
2020
Q1
$2.54M Buy
14,716
+418
+3% +$83.2K 2.66% 10
2019
Q4
$2.87M Buy
+14,298
New +$2.93M 2.59% 12

Other funds holding CME

Demars Financial Group's CME Position: Q2 2026 in Review

Demars Financial Group increased its CME Group (CME) stake by 33% in Q2 2026, buying an estimated $335K and bringing the position to 4,939 shares worth $1.09M. The position accounts for 0.3% of the portfolio, ranked #45.

Demars Financial Group first reported a position in CME in Q4 2019 and has held it in 14 quarters since. The position peaked at $2.87M in Q4 2019. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Demars Financial Group held 4,939 shares of CME Group worth $1.09M as of Q2 2026.
  • Demars Financial Group bought 1,212 CME Group shares in Q2 2026, an estimated $335K.
  • CME Group made up 0.3% of Demars Financial Group's portfolio in Q2 2026, its #45 holding.
  • Demars Financial Group first reported a position in CME Group in Q4 2019 and has held it in 14 quarters since.
  • Demars Financial Group's CME Group position peaked at $2.87M in Q4 2019.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Demars Financial Group's 13F filing for Q2 2026, filed 21 Jul 2026.